Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled study.

Terra JL, Montgomery SA.

Int Clin Psychopharmacol. 1998 Mar;13(2):55-62.

PMID:
9669185
2.

The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.

Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen RD, Yan B, Ahmed S, Musgnung J, Ninan PT.

J Clin Psychiatry. 2007 Aug;68(8):1246-56.

PMID:
17854250
3.

Fluoxetine in the prevention of depressive recurrences: a double-blind study.

Gilaberte I, Montejo AL, de la Gandara J, Perez-Sola V, Bernardo M, Massana J, Martin-Santos R, Santiso A, Noguera R, Casais L, Perez-Camo V, Arias M, Judge R; Fluoxetine Long-Term Study Group.

J Clin Psychopharmacol. 2001 Aug;21(4):417-24.

PMID:
11476126
4.

Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.

Claghorn JL, Earl CQ, Walczak DD, Stoner KA, Wong LF, Kanter D, Houser VP.

J Clin Psychopharmacol. 1996 Apr;16(2):113-20.

PMID:
8690826
5.

Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial.

Rossini D, Serretti A, Franchini L, Mandelli L, Smeraldi E, De Ronchi D, Zanardi R.

J Clin Psychopharmacol. 2005 Oct;25(5):471-5.

PMID:
16160624
6.

Escitalopram continuation treatment prevents relapse of depressive episodes.

Rapaport MH, Bose A, Zheng H.

J Clin Psychiatry. 2004 Jan;65(1):44-9.

PMID:
14744167
7.

Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy.

Klysner R, Bent-Hansen J, Hansen HL, Lunde M, Pleidrup E, Poulsen DL, Andersen M, Petersen HE.

Br J Psychiatry. 2002 Jul;181:29-35.

8.

Fluvoxamine in prevention of relapse in bulimia nervosa: effects on eating-specific psychopathology.

Fichter MM, Krüger R, Rief W, Holland R, Döhne J.

J Clin Psychopharmacol. 1996 Feb;16(1):9-18.

PMID:
8834413
9.

Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study.

Montgomery SA, Reimitz PE, Zivkov M.

Int Clin Psychopharmacol. 1998 Mar;13(2):63-73.

PMID:
9669186
10.

Prophylactic effect of citalopram in unipolar, recurrent depression: placebo-controlled study of maintenance therapy.

Hochstrasser B, Isaksen PM, Koponen H, Lauritzen L, Mahnert FA, Rouillon F, Wade AG, Andersen M, Pedersen SF, Swart JC, Nil R.

Br J Psychiatry. 2001 Apr;178:304-10.

11.

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.

Eur Neuropsychopharmacol. 2004 Dec;14(6):457-70.

PMID:
15589385
12.

Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients.

Fabre L, Birkhimer LJ, Zaborny BA, Wong LF, Kapik BM.

Int Clin Psychopharmacol. 1996 Jun;11(2):119-27.

PMID:
8803649
13.

Fluvoxamine-controlled release formulation for the treatment of generalized social anxiety disorder.

Davidson J, Yaryura-Tobias J, DuPont R, Stallings L, Barbato LM, van der Hoop RG, Li D.

J Clin Psychopharmacol. 2004 Apr;24(2):118-25.

PMID:
15206657
14.

A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling.

Hollander E, DeCaria CM, Finkell JN, Begaz T, Wong CM, Cartwright C.

Biol Psychiatry. 2000 May 1;47(9):813-7.

PMID:
10812040
15.

A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder.

Hollander E, Koran LM, Goodman WK, Greist JH, Ninan PT, Yang H, Li D, Barbato LM.

J Clin Psychiatry. 2003 Jun;64(6):640-7.

PMID:
12823077
16.

A double-blind study of long-term treatment with sertraline or fluvoxamine for prevention of highly recurrent unipolar depression.

Franchini L, Gasperini M, Perez J, Smeraldi E, Zanardi R.

J Clin Psychiatry. 1997 Mar;58(3):104-7.

PMID:
9108811
17.
18.

Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.

Erzegovesi S, Guglielmo E, Siliprandi F, Bellodi L.

Eur Neuropsychopharmacol. 2005 Jan;15(1):69-74.

PMID:
15572275
19.

A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.

Otsubo T, Akimoto Y, Yamada H, Koda R, Aoyama H, Tanaka K, Mimura M, Nakagome K, Kamijima K.

Pharmacopsychiatry. 2005 Jan;38(1):30-5.

PMID:
15706464
20.

Supplemental Content

Support Center